We are proud to announce that the Thailand Hub of Talent for Cancer Immunotherapy (TTCI) has been officially recognized as a member of the Society for Immunotherapy of Cancer (SITC) - World Immunotherapy Council (WIC). This significant achievement is marked by the appointment of our esteemed chair, Prof. Nattiya Hirankarn, as a committee member of the WIC-Asian Chapter.

The recognition was awarded during the WIC-Asian Chapter Pre-Conference Meeting held from June 28-29, 2024, at the Pudong Shangri-La in Shanghai, China. Prof. Hirankarn's appointment highlights TTCI's pivotal role in advancing cancer immunotherapy research and its growing influence in the global scientific community.

Prof. Hirankarn's inclusion as a committee member not only showcases her dedication and expertise but also strengthens the collaboration between TTCI and leading international researchers. This partnership aims to foster knowledge exchange, promote innovative research, and enhance the development of effective cancer immunotherapies.

The WIC-Asian Chapter Pre-Conference Meeting provided a platform for young investigators and key opinion leaders to connect, share insights, and discuss the latest discoveries in immunotherapy. Prof. Hirankarn's participation as a committee member is a testament to TTCI's commitment to excellence and its continuous contribution to the field of cancer immunotherapy.

We extend our heartfelt congratulations to Prof. Nattiya Hirankarn and Dr. Piriya Luangwattananun, who was also honored as a Young Investigator during the same conference. Their achievements bring immense pride to TTCI and inspire future generations of researchers.